Stockscreener 앱 받기
1.93
1.05%
0.02
시장 영업 전:
1.97
0.04
+2.07%
전일 마감가:
$1.91
열려 있는:
$1.95
하루 거래량:
967.23K
Relative Volume:
0.72
시가총액:
$189.64M
수익:
$11.16M
순이익/손실:
$-148.13M
주가수익비율:
-1.215
EPS:
-1.5885
순현금흐름:
$-112.35M
1주 성능:
-7.21%
1개월 성능:
-0.52%
6개월 성능:
-11.87%
1년 성능:
+124.76%
1일 변동 폭
$1.89
$1.985
1주일 범위
$1.83
$2.08
52주 변동 폭
$0.7301
$3.535
Caribou Biosciences Inc Stock (CRBU) Company Profile
명칭
Caribou Biosciences Inc
전화
510-982-6030
주소
2929 7TH STREET, SUITE 105, BERKELEY
Compare CRBU vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CRBU
Caribou Biosciences Inc
|
1.93 | 189.64M | 11.16M | -148.13M | -112.35M | -1.5885 |
VRTX
Vertex Pharmaceuticals Inc
|
424.36 | 107.87B | 12.32B | 4.34B | 3.19B | 16.86 |
REGN
Regeneron Pharmaceuticals Inc
|
702.27 | 73.63B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
794.70 | 49.42B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
301.11 | 40.20B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
297.49 | 33.06B | 5.36B | 287.73M | 924.18M | 2.5229 |
Caribou Biosciences Inc Stock (CRBU) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-06-03 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2023-11-08 | 개시 | Cantor Fitzgerald | Neutral |
| 2023-10-31 | 개시 | Evercore ISI | Outperform |
| 2023-07-11 | 개시 | Truist | Buy |
| 2022-02-18 | 개시 | RBC Capital Mkts | Outperform |
| 2021-12-01 | 개시 | Oppenheimer | Outperform |
| 2021-11-30 | 개시 | H.C. Wainwright | Buy |
| 2021-11-15 | 업그레이드 | Citigroup | Neutral → Buy |
| 2021-08-17 | 개시 | BofA Securities | Buy |
| 2021-08-17 | 개시 | Citigroup | Neutral |
| 2021-08-17 | 개시 | SVB Leerink | Outperform |
모두보기
Caribou Biosciences Inc 주식(CRBU)의 최신 뉴스
Caribou Biosciences to Participate in the BofA Securities 2026 Health Care Conference - Investing News Network
Caribou Biosciences to participate in BofA Securities Health Care event in Las Vegas - Traders Union
Caribou Biosciences (CRBU) price target decreased by 22.79% to 8.92 - MSN
MSN Money - MSN
Caribou Biosciences (CRBU) corrects record‑date shares, June 17 virtual annual meeting - Stock Titan
Caribou Biosciences Stock Soars Pre-market On Positive Early Trial Data For Cancer Treatments - MSN
Caribou Biosciences (NASDAQ:CRBU) Stock Price Down 2.3%Here's Why - MarketBeat
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Caribou Biosciences - TMX Newsfile
Caribou Biosciences (NASDAQ: CRBU) sets 2026 director, auditor and charter votes - Stock Titan
CRBU Earnings History & Surprises | EPS & Revenue Results | CARIBOU BIOSCIENCES INC (NASDAQ:CRBU) - ChartMill
CRBU Caribou Biosciences Inc. posts narrower Q4 2025 loss than consensus forecasts, shares rise 2.33 percent amid upbeat investor sentiment.Product Mix - Xã Thanh Hà
Where could Caribou Bio (CRBU) stock be by the end of 2026 (+4.67%) 2026-04-22Stock Screening - Xã Vĩnh Công
Is Agilon Health (AGL) Outperforming Other Medical Stocks This Year? - qz.com
CRBU SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Caribou Biosciences, Inc. Stockholders Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
CRBU SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Caribou Biosciences, Inc. Investors Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
CRBU Forecast, Price Target & Analyst Ratings | CARIBOU BIOSCIENCES INC (NASDAQ:CRBU) - ChartMill
Investment Recap: Should you avoid Caribou Biosciences Inc stock right now2026 Market WrapUp & AI Based Buy/Sell Signal Reports - baoquankhu1.vn
Caribou Biosciences (NASDAQ: CRBU) schedules virtual annual meeting June 17, 2026 - Stock Titan
CRBU Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Caribou Biosciences' (CRBU) Buy Rating Reaffirmed at HC Wainwright - MarketBeat
H.C. Wainwright Maintains Caribou Biosciences(CRBU.US) With Buy Rating, Maintains Target Price $9 - Moomoo
Earnings Miss: How does Caribou Biosciences Inc compare to its peersWeekly Profit Report & Long-Term Capital Growth Strategies - baoquankhu1.vn
CRBU SEC FilingsCaribou Biosciences, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
Caribou Biosciences, Inc. (CRBU) stock price, news, quote and history - sg.finance.yahoo.com
Alpha Cognition Inc. (ACOG) Jumps 8.6%: Does the Stock Have More Room to Grow? - Bitget
Caribou Biosciences Granted FDA RMAT Designation for CB-011 Allogeneic Anti-BCMA CAR-T Cell Therapy - Minichart
Caribou Biosciences, Inc. Announces the FDA Granted Regenerative Medicine Advanced Therapy Designation to CB-011, an Allogeneic Anti-BCMA CAR-T Cell Therapy - marketscreener.com
Caribou Biosciences Gains RMAT Status for CB-011 Therapy - TipRanks
Caribou Biosciences Announces the FDA Granted Regenerative Medicine Advanced Therapy Designation to CB-011, an Allogeneic Anti-BCMA CAR-T Cell Therapy - Investing News Network
Caribou Biosciences Announces the FDA Granted Regenerative Medicine Advanced Therapy (RMAT) Designation to CB-011, an Allogeneic Anti-BCMA CAR-T Cell Therapy - Bitget
Caribou rises on FDA RMAT designation (CRBU:NASDAQ) - Seeking Alpha
Caribou Biosciences Announces The FDA Granted Regenerative Medicine Advanced Therapy (Rmat) Designation To Cb-011 - TradingView
Caribou Biosciences receives FDA RMAT designation for CB-011 in multiple myeloma - tradersunion.com
FDA grants RMAT designation to Caribou (CRBU) CAR-T CB-011 in multiple myeloma - Stock Titan
FDA gives advanced therapy status to Caribou's myeloma CAR-T - Stock Titan
Fed Watch: Can Caribou Biosciences Inc expand its profit marginsMarket Activity Recap & Daily Profit Maximizing Trade Tips - baoquankhu1.vn
Is Caribou Biosciences Inc a cyclical or defensive stockWeekly Trade Recap & High Conviction Buy Zone Picks - baoquankhu1.vn
Caribou Biosciences (NASDAQ:CRBU) Stock Rating Upgraded by Truist Financial - marketbeat.com
Hedge Fund Moves: Is Caribou Biosciences Inc stock good for income investors2026 Retail Activity & Daily Market Momentum Tracking - baoquankhu1.vn
How does Caribou Biosciences Inc compare to its peersPortfolio Gains Report & Fast Gaining Stock Reports - baoquankhu1.vn
Caribou Biosciences stock faces pressure amid biotech sector volatility and pipeline updates - AD HOC NEWS
Bronstein, Gewirtz & Grossman, LLC Is Investigating Caribou Biosc - The National Law Review
Caribou Biosciences stock faces pressure amid biotech volatility and pipeline updates - AD HOC NEWS
Caribou Biosciences Shares Double After Strong Multiple Myeloma Trial Results - msn.com
Caribou Biosciences Inc (CRBU) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.14%
0.48%
자본화:
|
볼륨(24시간):